These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale and cryptogenic stroke: a matter of age? Handke M; Harloff A; Bode C; Geibel A Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041 [TBL] [Abstract][Full Text] [Related]
4. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials. Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192 [TBL] [Abstract][Full Text] [Related]
5. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients. Ueno Y; Shimada Y; Tanaka R; Miyamoto N; Tanaka Y; Hattori N; Urabe T Cerebrovasc Dis; 2010; 30(1):15-22. PubMed ID: 20424440 [TBL] [Abstract][Full Text] [Related]
7. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale. Turc G; Lee JY; Brochet E; Kim JS; Song JK; Mas JL; J Am Coll Cardiol; 2020 May; 75(18):2312-2320. PubMed ID: 32381162 [TBL] [Abstract][Full Text] [Related]
8. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W; Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390 [TBL] [Abstract][Full Text] [Related]
9. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events. Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911 [TBL] [Abstract][Full Text] [Related]
10. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults). Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A; Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111 [TBL] [Abstract][Full Text] [Related]
11. Clinical Relevance of Patent Foramen Ovale and Atrial Septum Aneurysm in Stroke: Findings of a Single-Center Cross-Sectional Study. Schnieder M; Siddiqui T; Karch A; Bähr M; Hasenfuss G; Liman J; Schroeter MR Eur Neurol; 2017; 78(5-6):264-269. PubMed ID: 28957815 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661 [TBL] [Abstract][Full Text] [Related]
13. Closure of patent foramen ovale in cryptogenic stroke: a never ending story. Calvet D; Mas JL Curr Opin Neurol; 2014 Feb; 27(1):13-9. PubMed ID: 24300793 [TBL] [Abstract][Full Text] [Related]
14. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L; Stroke; 2010 Dec; 41(12):2872-83. PubMed ID: 21051670 [TBL] [Abstract][Full Text] [Related]
15. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials. Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568 [TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study. Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661 [TBL] [Abstract][Full Text] [Related]
17. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189 [TBL] [Abstract][Full Text] [Related]
18. Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: An Update. Abdelghani M; El-Shedoudy SAO; Nassif M; Bouma BJ; de Winter RJ Cardiology; 2019; 143(1):62-72. PubMed ID: 31307049 [TBL] [Abstract][Full Text] [Related]
19. Ignored Role of Paroxysmal Atrial Fibrillation in the Pathophysiology of Cryptogenic Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm. Yetkin E; Atmaca H; Çuğlan B; Yalta K Curr Cardiol Rev; 2024; 20(2):14-19. PubMed ID: 38367262 [TBL] [Abstract][Full Text] [Related]